Faculty

Institution

Unit

Venue

Erika Lisabeth

Assistant Professor Fixed-Term and Director ADDRC Assistant Professor

Michigan State University

Affiliations

College of Human Medicine

Department of Pharmacology and Toxicology

Erika Lisabeth is currently serving as a College Of Human Medicine Assistant Professor Fixed-Term and Director ADDRC Assistant Professor at Michigan State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Erika Lisabeth

Michigan State University

Assistant Professor Fixed-Term and Director ADDRC Assistant Professor

You can click a keyword to filter the displayed items

pharmacology oncology medicinal research cell biology cancer biology neuroscience tumor biology cancer research enzyme inhibition dermatology cell signaling drug discovery cancer genomics cancer genetics medicinal chemistry molecular pharmacology pharmacotherapy molecular cancer oncogenes therapeutic efficacy melanoma regenerative medicine cancer cells leukemia respiratory medicine clinical pharmacology fibrosis novel therapies gene regulation transcription regulation antibody engineering cancer treatment tumor targeting de-differentiated melanoma cells protein science brain tumor research mammalian biology applied physiology applied microbiology biopolymers liver physiology vascular biology receptor tyrosine kinases pharmaceutical sciences systemic scleroderma pharmaceutical biotechnology skin cancer pathway analysis bio-based materials biomaterials design biopolymer gel anti-inflammatory bioceramics signaling pathways cell regulation pulmonary arterial hypertension angiogenesis cardiovascular pharmacology analytical biotechnology high-throughput screening anti-cancer agents cancer somatic mutations multiple mechanisms local delivery preclinical model coexpressed ephrin ligands novel inhibitors pharmacokinetic optimitzation antimetastatic compounds molecular target small-molecule inhibition prostate cancer cells metastasis gene networks er stress immune cell populations anti-inflammatory properties photocarcinogenesis carcinogenesis

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4474: Novel Analogs of 4-Substituted Pyrrolo[2,3- D ]Pyrimidines as Dual-Targeted Megfr/Aurka Inhibitors for Lung Cancer. Cancer Research (2024)

Sonali KurupGabe CarpenterSamantha SatawaFelix AmissahErika LisabethMatthew GilettoEdmund Ellsworth

drug targetinganti-cancer agentsgliomaspharmacologythoracic oncologylung cancercancer researchdrug discoverypharmacotherapycancer treatmenthealth sciencesradiation oncologymedicinal researchcellular therapycancer carecancer biologytumor targetingnovel analogsoncology

Development of an Srf Inhibitor Peptide for the Treatment of Cardiac Fibrosis. Spartan Medical Research Journal (2024)

Melissa HerschkowitzErika LisabethRichard Neubig

fibrosisbiomedical researchmedicinal researchpeptidescardiac fibrosissrf inhibitor peptidemedicineclinical research

Development of a Srf Inhibitor Peptide for the Treatment of Cardiac Fibrosis. Journal of Pharmacology and Experimental Therapeutics (2024)

Melissa MeschkewitzErika M. LisabethRichard R. Neubig

inflammationcardiologyenzyme specificitypeptide engineeringmedicinal researchpeptide sciencebiomarker targetbiochemistrypeptidescardiac fibrosisprotein engineeringmolecular biologypharmacologytherapeutic targetsmolecular engineeringsrf inhibitor peptideenzyme inhibitiontherapeutic efficacy

Pirin Does Not Bind to P65 or Regulate Nfkappab-Dependent Gene Expression. bioRxiv (Cold Spring Harbor Laboratory) (2024)

Melissa MeschkewitzErika M LisabethA. Denaly Cab-GomezJeffrey LeipprandtRichard R Neubig

oncogenesnfkappab-dependent gene expressioncancer biologytranscription factorsgene regulationbiologytranscription regulationmolecular biologygene expressiongene regulatory networksgenetics

Development and Validation of a High-Throughput Cell-Based Alphalisa Assay to Identify Small Molecule 20S Proteasome Modulators. Journal of Pharmacology and Experimental Therapeutics (2023)

Erika LisabethSophia StaerzEvert NjomenThomas DexheimerRichard NeubigJetze Tepe

proteomicshigh-throughput cell-based alphalisasmall moleculesproteasome modulatorsbiomolecular engineering

Development of a 5-Ht7 Receptor Antibody for the Rat: The Good, the Bad, and the Ugly. Naunyn-Schmiedeberg s Archives of Pharmacology (2023)

Janice M. ThompsonWill TraggeEmma D. FloodStefan SchulzErika LisabethStephanie W. Watts

immunologyneuroscienceantibody engineeringpharmacologyreceptors

Development of a Cell-Based Alphalisa Assay for High-Throughput Screening for Small Molecule Proteasome Modulators. ACS Omega (2023)

Sophia D. StaerzErika M. LisabethEvert NjomenThomas S. DexheimerRichard R. NeubigJetze J. Tepe

high-throughput screeninganalytical biotechnologyproteomicscell-based alphalisa assaycell biologybiomolecular engineering

Revisiting Pirin: Evidence for a Role in Translation but Not in Transcriptional Control. Journal of Pharmacology and Experimental Therapeutics (2023)

Anna Denaly Cab GomezRichard NeubigErika M. Lisabeth

transcriptional controlcell biologygenetics

Supplemental Figure 1 From Pharmacological Inhibition of Myocardin-Related Transcription Factor Pathway Blocks Lung Metastases of Rhoc-Overexpressing Melanoma. (2023)

Andrew J. HaakKathryn M. AppletonErika M. LisabethSean A. MisekYajing JiSusan M. WadeJessica L. BellCheryl E. RockwellMerlin AirikMelanie A. KrookScott D. LarsenMonique VerhaegenElizabeth R. LawlorRichard R. Neubig

pharmacological inhibitionpharmacologythoracic oncologytranscription factorsmelanomalung cancercancer researchtumor suppressorsradiation oncologyrespiratory medicinecellular therapycancer managementcancer careneurologymetastasistumor targetingcancer growthrhoc-overexpressing melanomaenzyme inhibitiononcology

Without a Trace: The Pirin and Nf-κB Interaction. Journal of Pharmacology and Experimental Therapeutics (2023)

Melissa MeschkewitzErika M. LisabethRichard Neubig

biophysicsnf-kb interactionmolecular biology

1
2
3
10 / page

Erika Lisabeth

Assistant Professor Fixed-Term and Director ADDRC Assistant Professor

Michigan State University

Affiliations

College of Human Medicine

Department of Pharmacology and Toxicology

Erika Lisabeth is currently serving as a College Of Human Medicine Assistant Professor Fixed-Term and Director ADDRC Assistant Professor at Michigan State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Erika Lisabeth

Michigan State University

Assistant Professor Fixed-Term and Director ADDRC Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4474: Novel Analogs of 4-Substituted Pyrrolo[2,3- D ]Pyrimidines as Dual-Targeted Megfr/Aurka Inhibitors for Lung Cancer. Cancer Research (2024)

Sonali KurupGabe CarpenterSamantha SatawaFelix AmissahErika LisabethMatthew GilettoEdmund Ellsworth

Development of an Srf Inhibitor Peptide for the Treatment of Cardiac Fibrosis. Spartan Medical Research Journal (2024)

Melissa HerschkowitzErika LisabethRichard Neubig

fibrosisbiomedical researchmedicinal researchpeptidescardiac fibrosissrf inhibitor peptidemedicineclinical research

Development of a Srf Inhibitor Peptide for the Treatment of Cardiac Fibrosis. Journal of Pharmacology and Experimental Therapeutics (2024)

Melissa MeschkewitzErika M. LisabethRichard R. Neubig

Pirin Does Not Bind to P65 or Regulate Nfkappab-Dependent Gene Expression. bioRxiv (Cold Spring Harbor Laboratory) (2024)

Melissa MeschkewitzErika M LisabethA. Denaly Cab-GomezJeffrey LeipprandtRichard R Neubig

oncogenesnfkappab-dependent gene expressioncancer biologytranscription factorsgene regulationbiologytranscription regulationmolecular biologygene expressiongene regulatory networksgenetics

Development and Validation of a High-Throughput Cell-Based Alphalisa Assay to Identify Small Molecule 20S Proteasome Modulators. Journal of Pharmacology and Experimental Therapeutics (2023)

Erika LisabethSophia StaerzEvert NjomenThomas DexheimerRichard NeubigJetze Tepe

proteomicshigh-throughput cell-based alphalisasmall moleculesproteasome modulatorsbiomolecular engineering

Development of a 5-Ht7 Receptor Antibody for the Rat: The Good, the Bad, and the Ugly. Naunyn-Schmiedeberg s Archives of Pharmacology (2023)

Janice M. ThompsonWill TraggeEmma D. FloodStefan SchulzErika LisabethStephanie W. Watts

immunologyneuroscienceantibody engineeringpharmacologyreceptors

Development of a Cell-Based Alphalisa Assay for High-Throughput Screening for Small Molecule Proteasome Modulators. ACS Omega (2023)

Sophia D. StaerzErika M. LisabethEvert NjomenThomas S. DexheimerRichard R. NeubigJetze J. Tepe

high-throughput screeninganalytical biotechnologyproteomicscell-based alphalisa assaycell biologybiomolecular engineering

Revisiting Pirin: Evidence for a Role in Translation but Not in Transcriptional Control. Journal of Pharmacology and Experimental Therapeutics (2023)

Anna Denaly Cab GomezRichard NeubigErika M. Lisabeth

transcriptional controlcell biologygenetics

Supplemental Figure 1 From Pharmacological Inhibition of Myocardin-Related Transcription Factor Pathway Blocks Lung Metastases of Rhoc-Overexpressing Melanoma. (2023)

Without a Trace: The Pirin and Nf-κB Interaction. Journal of Pharmacology and Experimental Therapeutics (2023)

Melissa MeschkewitzErika M. LisabethRichard Neubig

biophysicsnf-kb interactionmolecular biology

1
2
3
10 / page

Similar Faculty Members

Karen T. Liby

Institution

Michigan State University

pharmacology

oncology

Dhimant Desai

Institution

Pennsylvania State University

future medicinal chemistry

organic chemistry

Georg T Wondrak

Institution

University of Arizona

toxicology

biochemistry

Adrienne Cox

Institution

University of North Carolina at Chapel Hill

molecular cancer

carcinogenesis

Ruiwen Zhang

Institution

University of Houston

cancer therapy

anti-cancer agent

Vito Quaranta, M.D.

Institution

Vanderbilt University

biosystems

ordinary differential equations

Alan Tackett

Institution

University of Arkansas

molecular biology

genetics

Chi Wang

Institution

University of Kentucky

cancer research

oncology

Axel Schonthal, PhD

Institution

University of Southern California

brain tumor research

malignant disease

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon

Similar Faculty Members

Karen T. Liby

Institution

Michigan State University

pharmacology

oncology

Dhimant Desai

Institution

Pennsylvania State University

future medicinal chemistry

organic chemistry

Georg T Wondrak

Institution

University of Arizona

toxicology

biochemistry

Adrienne Cox

Institution

University of North Carolina at Chapel Hill

molecular cancer

carcinogenesis

Ruiwen Zhang

Institution

University of Houston

cancer therapy

anti-cancer agent

Vito Quaranta, M.D.

Institution

Vanderbilt University

biosystems

ordinary differential equations

Alan Tackett

Institution

University of Arkansas

molecular biology

genetics

Chi Wang

Institution

University of Kentucky

cancer research

oncology

Axel Schonthal, PhD

Institution

University of Southern California

brain tumor research

malignant disease

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon